S&P 500 Retreats as AI Speculation Deflates with Arrival of Lower Cost Competition
The S&P 500 (Index: SPX) retreated 1.5% from its previous week’s close to end the week at 7,457.69.
Much of the market’s downward movement came in response to a growing awareness among investors of the high cost of utilizing the most advanced AI systems over the last several weeks. The shift in sentiment has largely capped the upward movement of these stocks despite many having just reported strong earnings.
But it hasn’t deflated the S&P 500 the way the index crashed during 2025′s “DeepSeek” scare, which one analyst provocatively described as “hiding” a crashing market brought about by investors rotating their investments from AI tech stocks into other sectors of the market.
That’s a phenomenon we’ve described as the conveyance effect. This is a special case of market rotation, in which the gains of what might be described as a speculative bubble within either a single stock or sector of the stock market becomes diffused into the larger market.
Provided investors maintain their demand to own stocks, it can be a healthy development that reduces the concentration of the biggest companies within the market cap-weighted index. In that situation, the index itself goes through a brief decline before resuming an upward trajectory.
If that demand falls however, the index can decline because money is in effect leaving the market instead of being conveyed into the ownership of other stocks within it. That’s the recipe for a crash that takes both the sector with the speculative gain and the rest of the market down with it. Much like what happened during the DeepSeek scare.
In the latest update of the alternative futures chart, we find the S&P 500′s trajectory dipped, but remains well within the redzone forecast range. This outcome indicates the deflation of speculative gains in the AI sector hasn’t become a drag on the whole stock market.
There is, of course, more going on to shape investors’ outlook for the businesses whose stocks make up S&P 500 index. Here are the market moving headlines of the week that was:
- Monday, 13 July 2026
-
- Signs and portents for the U.S. economy:
- This one statistic reveals the AI job takeover has started
- Wall Street banks ramp up digital assistants in bid to win productivity race
- AI isn’t killing jobs at these companies — it’s boosting hiring
- Fed minion makes rate hike nearly a 50-50 possibility for July 2026:
- Bigger trouble, stimulus developing in China:
- China’s GDP growth set to slow, raising expectations for more stimulus
- China June exports growth set to cool, but AI demand underpins overall strength – Reuters poll
- China’s premier urges ‘objective’ understanding of the economy
- China aims to spur consumption in first five-year blueprint
- BOJ minions think higher growth on the way for Japan’s economy as stimulus expected:
- BOJ may raise growth forecast, maintain vigilance to inflation risk, sources say
- Japan signals massive pension shift to domestic assets, sparking rally in yen, bonds
- ECB minions thinking about adding Eurocrypto as Eurozone currency:
- U.S. stocks end lower as chip stocks fall, U.S.-Iran tensions rise
- Tuesday, 14 July 2026
-
- Signs and portents for the U.S. economy:
- US consumer inflation likely increased at a slow pace in June as gasoline prices retreated
- Here’s the inflation breakdown for June 2026 — in one chart
- Rate-Hike Odds Slump As US Consumer Prices Plunge Most Since COVID In June
- Traders expect Fed to skip July rate hike as inflation cools
- Oil prices rise 2% to one-month high as US-Iran attacks deepen supply disruption
- New chief Fed minion lays out U.S. monetary policy changes to Congress:
- Fed’s Warsh: Committed to both inflation and employment mandates
- Warsh pledges Fed policy ‘regime change’ to rid inflation ‘tax’ on American people
- Warsh says markets to get ample notice to any Fed balance sheet changes
- Growth in China’s exports paced by AI demand outside China, weak demand for loans within China:
- China’s June trade tops forecasts buoyed by AI boom
- China tells some banks not to re-discount bills at rates below 0.5%, sources say
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- Wednesday, 15 July 2026
-
- Signs and portents for the U.S. economy:
- Busiest US container port sets cargo record in June
- Oil prices make small gain on smaller US inventory draw
- Wall Street bank earnings surge, lifted by trading and investment banking
- Fed minion reveals they’re not really paying attention to U.S. inflation data:
- Another minion sees the writing on the wall:
- Fed minions thinking about revamping their own inflation measure:
- Bigger trouble developing in China:
- VIEW China’s second-quarter economic growth misses market forecast
- China new home prices fall at slower pace, but recovery doubtful
- China’s rare earth curbs endanger $6.5 trillion of Western industry, IEA says
- BOJ minions / Bigger trouble developing in Japan:
- ECB minions standing by for action:
- Wall Street closes higher as the tech trade strengthens, wholesale inflation comes cooler
- Thursday, 16 July 2026
-
- Signs and portents for the U.S. economy:
- US pending home sales slump in June amid affordability challenges
- Lower gasoline prices restrain US retail sales, underlying momentum remains
- Fed minions called out for policy flip-flops:
- As Fed Chair Warsh sticks to policy silence, colleagues voice their views
- Fed flip-flops make case for less talk
- Fed minions say they’ll hike rates if inflation doesn’t fall, don’t seem to be aware of consumer, producer price indices:
- Fed may need to hike rates if inflation does not ease soon, Jefferson says
- Fed’s Schmid: Inflation is “concerning” and the focus of setting policy right now
- Fed’s Logan calls for ‘modestly higher’ interest rates
- Bigger trouble, stimulus developing in China:
- Bigger trouble developing in Japan, BOJ minions getting excited to hike Japan’s interest rates again, bail out Japan’s currency again:
- Kuroda’s negative rate surprise shocked his own BOJ board, minutes show
- Japan household inflation expectations rise, build case for BOJ rate hikes
- BOJ may face pressure to ramp up bond-buying if yields spike, ex-central bank policymaker says
- ECB minions standing by to hike Eurozone interest rates later:
- ECB to hold rates now but energy price resurgence points to September hike
- Euro zone yields rise, gap between German and US borrowing costs smallest in a month
- Wall Street closes in the red as tech stocks drag markets
- Friday, 17 July 2026
-
- Signs and portents for the U.S. economy:
- As US AI costs soar, global businesses pivot to China’s low-cost, open-weight models
- Oil rises on renewed US-Iran hostilities and threat of Red Sea closure
- US regional banks brush off war jitters with lending surge, fee boost
- Bigger trouble developing in and out of China:
- China’s oil imports have plunged during the Iran war. How much will they recover?
- China’s top airlines warn of heavy losses ahead of uncertain summer
- Inside the Chinese fraud rings stealing billio
- Chinese AI start-up Moonshot launches model challenging Anthropic’s lead
- Bigger trouble developing in Japan, BOJ minions standing by for action:
- Japan June core inflation seen at 1.6% on elevated energy prices: Reuters poll
- Yen likely to weaken past 170 before Japan’s growth bet pays off, RSM’s Brusuelas says
- Japan to leave monetary policy tools to BOJ in economic blueprint, document shows
- S&P 500 logs weekly decline as tech selloff weighs on markets
The CME Group’s FedWatch Tool now only sees one rate hike in its forecast range as having a greater than 50% probability of happening: a quarter point rate hike coming when the Fed meets on 16 September (2026-Q3). The FedWatch tool however still sees the potential for additional rate hikes in 2027.
The Atlanta Fed’s GDPNow tool‘s estimate of real GDP growth for the U.S. economy in the current quarter of 2026-Q2 rebounded to +1.7% from the previous week’s real growth estimate of +1.2%.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull who is shocked by the cost of their AI bill”.
Source: https://politicalcalculations.blogspot.com/2026/07/s-500-retreats-as-ai-speculation.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



